These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study. Agorastos T, Chatzistamatiou K, Moysiadis T, Kaufmann AM, Skenderi A, Lekka I, Koch I, Soutschek E, Boecher O, Kilintzis V, Angelidou S, Katsiki E, Hagemann I, Boschetti Gruetzmacher E, Tsertanidou A, Angelis L, Maglaveras N, Jansen-Duerr P. Int J Cancer; 2017 Aug 01; 141(3):519-530. PubMed ID: 28470689 [Abstract] [Full Text] [Related]
5. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico. Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J, FRIDA Study Group.. JAMA Netw Open; 2019 Nov 01; 2(11):e1915781. PubMed ID: 31747033 [Abstract] [Full Text] [Related]
7. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, Gertig D, Jennett CJ, Farnsworth A, Tan J, Wrede CD, Castle PE, Saville M. PLoS Med; 2017 Sep 01; 14(9):e1002388. PubMed ID: 28926579 [Abstract] [Full Text] [Related]
8. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping. Hernández-López R, Lorincz AT, Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, Nedjai B, Mendiola-Pastrana I, León-Maldonado L, Rivera-Paredez B, Ramírez-Palacios P, Lazcano-Ponce E, Cuzick J, Salmerón J, FRIDA Study Group. Clin Epigenetics; 2019 Oct 12; 11(1):140. PubMed ID: 31606044 [Abstract] [Full Text] [Related]
9. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC, HERMES study group. PLoS One; 2015 Oct 12; 10(3):e0119755. PubMed ID: 25793281 [Abstract] [Full Text] [Related]
11. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy. Dijkstra MG, van Niekerk D, Rijkaart DC, van Kemenade FJ, Heideman DA, Snijders PJ, Meijer CJ, Berkhof J. Cancer Epidemiol Biomarkers Prev; 2014 Jan 12; 23(1):55-63. PubMed ID: 23733907 [Abstract] [Full Text] [Related]
12. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL. Gynecol Oncol; 2014 May 12; 133(2):172-9. PubMed ID: 24631450 [Abstract] [Full Text] [Related]
13. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting. Poljak M, Oštrbenk A, Seme K, Šterbenc A, Jančar N, Vrtačnik Bokal E. J Clin Virol; 2016 Mar 12; 76 Suppl 1():S29-S39. PubMed ID: 26643051 [Abstract] [Full Text] [Related]
15. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage. Yu L, Jiang M, Qu P, Wu Z, Sun P, Xi M, Qin Y, Liu X, Liao G, Lei X, Sun L, Zhang Y, Li Z, Chen W, Qiao YL. Int J Cancer; 2018 Aug 15; 143(4):813-822. PubMed ID: 29524206 [Abstract] [Full Text] [Related]
16. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women. Aoyama-Kikawa S, Fujita H, Hanley SJB, Kasamo M, Kikuchi K, Torigoe T, Matsuno Y, Tamakoshi A, Sasaki T, Matsuura M, Kato Y, Dong P, Watari H, Saito T, Sengoku K, Sakuragi N. Cancer Sci; 2018 Jun 15; 109(6):2003-2012. PubMed ID: 29660849 [Abstract] [Full Text] [Related]
17. Performance of HPV16/18 in Triage of Cytological Atypical Squamous Cells of Undetermined Significance. Cao X, Liu S, Jia M, Chen H, Zhao D, Dong B, Guo Z, Ren L, Zhang S, Sun X. Anal Cell Pathol (Amst); 2019 Jun 15; 2019():4324710. PubMed ID: 31934532 [Abstract] [Full Text] [Related]
19. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain. Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S. BMC Infect Dis; 2012 Jan 26; 12():25. PubMed ID: 22280073 [Abstract] [Full Text] [Related]
20. Clinical efficacy of primary human papillomavirus (HPV) screening with partial genotyping for HPV-16 and HPV-18 subtypes in women from 25 years old. Ang JX, Lee WY, Tay SK. Ann Acad Med Singap; 2023 May 30; 52(5):259-267. PubMed ID: 38904523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]